Emerging technologies for the identification of therapeutic targets for the management of pre-eclampsia.

Pritlove DC., Tan BK., de Wit NCJ., Vatish M.

Pre-eclampsia is a common and serious complication of pregnancy characterised by hypertension and proteinuria. Genetic and environmental factors influence the occurrence and progression of the disease. Emerging experimental systems and increasingly specific analytical methods for the study of differences between normal and pre-eclamptic placentae are close to identifying specific indicators of disease, which may allow early diagnosis and intervention and reveal targets against which therapeutic agents can be developed.

DOI

10.1517/14728222.8.6.507

Type

Journal article

Publication Date

2004-12-01T00:00:00+00:00

Volume

8

Pages

507 - 514

Total pages

7

Keywords

Adult, Animals, Blood Proteins, Case Management, Cell Fractionation, Computational Biology, Cyclin-Dependent Kinase Inhibitor p57, Female, Gene Expression Profiling, Genetic Predisposition to Disease, Humans, Hypertension, Insulin-Like Growth Factor II, Ischemia, Mice, Mice, Knockout, Mice, Mutant Strains, Mice, Transgenic, Nuclear Proteins, Placenta, Pre-Eclampsia, Pregnancy, Proteomics, Renin-Angiotensin System, Risk Factors, Vasoconstriction

Permalink More information Close